FDA introduces new guidance for mammography
This article was originally published in Clinica
The US FDA has been actively seeking to educate the lay public and healthcare providers about its new final regulations implementing the 1992 Mammography Quality Standards Act which go into effect on April 28.
You may also be interested in...
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.